Weiss Ratings Reiterates Sell (D-) Rating for Teladoc Health (NYSE:TDOC)

Key Points

• Weiss Ratings has reiterated Teladoc Health's stock rating as "sell (D-)", reflecting ongoing concerns about the company's performance.
• Teladoc reported a quarterly loss of ($0.19) earnings per share, which was better than the consensus estimate of ($0.27), but revenue fell 1.6% year-over-year.
• Institutional investors have increased their holdings in Teladoc Health, with notable raises including a 60.8% increase by Cambridge Investment Research Advisors.

Teladoc Health (NYSE:TDOC - Get Free Report)'s stock had its "sell (d-)" rating reissued by Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Other research analysts have also recently issued research reports about the company. Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price target for the company. Evercore ISI upped their price objective on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research report on Wednesday. Six investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $9.86.

Teladoc Health Trading Up 8.7%

Shares of TDOC stock traded up $0.73 during trading hours on Wednesday, reaching $9.10. The company's stock had a trading volume of 12,384,123 shares, compared to its average volume of 7,247,563. The stock has a market capitalization of $1.61 billion, a P/E ratio of -7.65 and a beta of 1.90. Teladoc Health has a one year low of $6.35 and a one year high of $15.21. The firm's fifty day simple moving average is $7.72 and its 200 day simple moving average is $7.61. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same period in the previous year, the company posted ($0.38) earnings per share. The firm's revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Equities research analysts expect that Teladoc Health will post -1.16 EPS for the current year.

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after buying an additional 15,030 shares during the period. Golden State Wealth Management LLC raised its holdings in shares of Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after buying an additional 1,690 shares during the period. Wedmont Private Capital raised its holdings in shares of Teladoc Health by 20.3% in the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after buying an additional 2,715 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Teladoc Health by 22.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after buying an additional 2,662 shares during the period. Finally, American Century Companies Inc. raised its holdings in shares of Teladoc Health by 78.8% in the first quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider's stock worth $2,985,000 after buying an additional 165,332 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.